Takeda to Present Oncology Portfolio and Pipeline Data at the 2023 ASCO Annual Meeting and EHA Congress

Author's Avatar
May 26, 2023

Takeda %28TSE%3A+4502%2FNYSE%3ATAK%29 today announced that it will present data from its expanding oncology pipeline and established product portfolio at the 59th+Annual+Meeting+of+the+American+Society+of+Clinical+Oncology (ASCO) being held June 2-6, 2023, in Chicago, Ill. and the 31st+Congress+of+the+European+Hematology+Association (EHA), June 8-11, 2023, in Frankfurt, Germany.